Biotech raises $96M IPO during downturn

While stock markets buckle under the pressures of the COVID-19 outbreak, a Lexington biotech developing drugs for blood and musculoskeletal disorders has raised an upsized IPO. Read More

Read More

Five minutes with … Kathy MacNeil, Millennium Partners

Kathy MacNeil, a principal at Millennium Partners in Boston who oversees Winthrop Center, a $1.3 billion mixed-use project in downtown Boston, spoke with the Business Journal about what’s it’s like to do business in the middle of a political battle over construction. Read More

Read More